Kevin R. Petrie

Sunderland, ENG SR13SD, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Targeting Glutaminolysis Shows Efficacy in Both Prednisolone-Sensitive and in Metabolically Rewired Prednisolone-Resistant B-Cell Childhood Acute Lymphoblastic Leukaemia Cells.

Targeting Glutaminolysis Shows Efficacy in Both Prednisolone-Sensitive and in Metabolically Rewired Prednisolone-Resistant B-Cell Childhood Acute Lymphoblastic Leukaemia Cells.

Journal: International journal of molecular sciences

Published: December 23, 2022

Suppression of MYC by PI3K/AKT/mTOR pathway inhibition in combination with all-trans retinoic acid treatment for therapeutic gain in acute myeloid leukaemia.

Suppression of MYC by PI3K/AKT/mTOR pathway inhibition in combination with all-trans retinoic acid treatment for therapeutic gain in acute myeloid leukaemia.

Journal: British journal of haematology

Published: January 13, 2022

The biguanide polyamine analog verlindamycin promotes differentiation in neuroblastoma via induction of antizyme.

The biguanide polyamine analog verlindamycin promotes differentiation in neuroblastoma via induction of antizyme.

Journal: Cancer gene therapy

Published: April 30, 2021

The RARγ Oncogene: An Achilles Heel for Some Cancers.

The RARγ Oncogene: An Achilles Heel for Some Cancers.

Journal: International journal of molecular sciences

Published: March 10, 2021

The Protozoan Inhibitor Atovaquone Affects Mitochondrial Respiration and Shows In Vitro Efficacy Against Glucocorticoid-Resistant Cells in Childhood B-Cell Acute Lymphoblastic Leukaemia.

The Protozoan Inhibitor Atovaquone Affects Mitochondrial Respiration and Shows In Vitro Efficacy Against Glucocorticoid-Resistant Cells in Childhood B-Cell Acute Lymphoblastic Leukaemia.

Journal: Frontiers in oncology

Published: November 22, 2020

Retinoic acid receptor γ is a therapeutically targetable driver of growth and survival in prostate cancer.

Retinoic acid receptor γ is a therapeutically targetable driver of growth and survival in prostate cancer.

Journal: Cancer reports (Hoboken, N.J.)

Published: May 22, 2020

Correction: The acetyltransferase GCN5 maintains ATRA-resistance in non-APL AML.

Correction: The acetyltransferase GCN5 maintains ATRA-resistance in non-APL AML.

Journal: Leukemia

Published: January 18, 2020

The acetyltransferase GCN5 maintains ATRA-resistance in non-APL AML.

The acetyltransferase GCN5 maintains ATRA-resistance in non-APL AML.

Journal: Leukemia

Published: June 21, 2019

Semi-Quantitative Mass Spectrometry in AML Cells Identifies New Non-Genomic Targets of the EZH2 Methyltransferase.

Semi-Quantitative Mass Spectrometry in AML Cells Identifies New Non-Genomic Targets of the EZH2 Methyltransferase.

Journal: International journal of molecular sciences

Published: June 10, 2017

A Case of AML Characterized by a Novel t(4;15)(q31;q22) Translocation That Confers a Growth-Stimulatory Response to Retinoid-Based Therapy.

A Case of AML Characterized by a Novel t(4;15)(q31;q22) Translocation That Confers a Growth-Stimulatory Response to Retinoid-Based Therapy.

Journal: International journal of molecular sciences

Published: June 06, 2017

Deregulated expression of HDAC9 in B cells promotes development of lymphoproliferative disease and lymphoma in mice.

Deregulated expression of HDAC9 in B cells promotes development of lymphoproliferative disease and lymphoma in mice.

Journal: Disease models & mechanisms

Published: January 26, 2016

p53 Loss in MYC-Driven Neuroblastoma Leads to Metabolic Adaptations Supporting Radioresistance.

p53 Loss in MYC-Driven Neuroblastoma Leads to Metabolic Adaptations Supporting Radioresistance.

Journal: Cancer research

Published: July 20, 2015

Showing 1-12 of 20

Last Updated: 09/26/2026